AstraZeneca’s Breakthrough in COVID-19 Protection for High-Risk Patients
Rare Blood Clots From J&J, Astra Covid Shots Linked to Genetics
AstraZeneca CEO Granted Performance-Based Shares
Five Things You Need to Know to Start Your Day: Europe
AstraZeneca Withdraws Covid-19 Vaccine, Citing Lack of Demand
Here Are the Obesity Drug Hopefuls Vying to Unseat Ozempic, Zepbound
Are British CEOs Paid Too Little? Wrong Question
AstraZeneca’s Calquence Sets New Standard in Lymphoma Care
AstraZeneca Shares Voting Rights Update
AstraZeneca Shares Voting Rights Update
AstraZeneca’s New Breast Cancer Treatment Nears EU Approval
AstraZeneca’s New Breast Cancer Treatment Nears EU Approval
Why UK Giants Should Think Twice Before Ditching London Listing
Earnings Slew: The Bloomberg Close, Europe Edition
AbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
London Stock Exchange Boss to Join Ranks of UK’s Highest Paid Execs
AstraZeneca Sees Strong Growth in Q1 2024
AstraZeneca Sees Strong Growth in Q1 2024
AstraZeneca’s Profit Gains on Sales of Cancer Drugs
How 4% Could Be the New Inflation Target
Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.